Novartis notes activities Mipharm, Novartis Korea

Release Date: 2009-05-07

Novartis aquired Mipharm, Italian generic company.

Generic Italian company Mipharm was sold to Novartis, which already owns 10% of the company. Mipharm will focus on the development and manufacture of generic and "supergenerici" and buy new products from Sandoz, Novartis division that deals with general practitioners.
Type: NORMAL
Company: Novartis Korea
Country: Republic of Korea
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.